金城醫藥(300233.SZ):過户登記完成 睿億投資成為公司持股5%以上股東
格隆匯 8 月 5日丨金城醫藥(300233.SZ)公佈,公司於2020年8月5日接到持股5%以上股東北京錦聖投資中心(“錦聖基金”)通知,其協議轉讓部分公司股份事宜已在中國證券登記結算有限責任公司辦理完成過户登記手續。
此前披露,2020年7月16日,錦聖基金與上海睿億投資發展中心(有限合夥)(“睿億投資”)簽署《股份轉讓協議》,錦聖基金將其持有的金城醫藥2000萬股無限售流通股協議轉讓給睿億投資。
目前,上述協議轉讓股份已在中國證券登記結算有限責任公司辦理完成過户登記手續,並收到了中國證券登記結算有限責任公司出具的《證券過户登記確認書》,過户日期為2020年8月4日。
此次股份轉讓過户手續完成後,錦聖基金持有公司約7064.38萬股股份,佔公司總股本的18.18%;睿億投資持有公司2000萬股股份,佔公司總股本的5.15%,成為公司持股5%以上股東。此次協議轉讓股份事項未導致公司控股股東及實際控制人發生變更。(説明:公告在計算相關股份比例時,總股本已剔除公司回購專用賬户中的股份數量。)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.